# A Study of XS-02 Capsules in Patients With Advanced Solid Tumors

> **NCT06531486** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **NovaOnco Therapeutics Co., Ltd.** · enrollment: 96 (estimated)

## Conditions studied

- Solid Tumor
- Ovarian Cancer
- Breast Cancer
- Endometrial Cancer

## Interventions

- **OTHER:** XS-02 capsules

## Key facts

- **NCT ID:** NCT06531486
- **Lead sponsor:** NovaOnco Therapeutics Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-07-29
- **Primary completion:** 2027-02-28
- **Final completion:** 2027-08-30
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2024-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06531486

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06531486, "A Study of XS-02 Capsules in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06531486. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*